REPRESENTATIVES OF PRIVATE INDUSTRY, 
NIH MEETING ON RECOMBINANT DNA GUIDELINES 
JUNE 2, 1976 
Organization 
Abbott Laboratories 
American Type Culture 
Collection 
Bell Telephone Laboratories, 
Inc. 
Burroughs Wellcome 
Cetus Corporation 
Ciba-Geigy Corporation 
Invited 
Ira Ringler, Ph.D. 
Corporate Vice President 
Research & Experimental 
Therapy 
Dr. Richard Donovick 
Director 
Dr. William 0. Baker 
President 
Dr. Pedro Cuatrecasas 
Vice President for 
Research 
Ronald Cape, Ph.D. 
President 
Dr. Karl J. Brunings 
Vice President 
Pharmaceutical Division 
Office of Environmental Affairs, W. Vern Hartwell, Ph.D. 
Department of Commerce Environmental Health 
Specialist 
Dow Chemical Company Dr. D. J. Kilian 
Regional Director 
Occupational Health & 
Medical Research for Dow, 
U.S. Area 
Dupont Company 
General Electric Company 
Dr. C. C. McDonald 
Research Supervisor 
Central Research and 
Development Dept. 
Mr. Arthur M. Bueche 
Vice President for 
Research 
W. R. Grace & Company 
Dr. Louis G. Nickell 
Vice President 
BioProducts Research Dept. 
Attended 
Dr. Lacy Overby 
Director 
Experimental Biology 
Dr. Richard Donovick 
Dr. James J. Burchall 
Head, Department of 
Microb iology 
Ronald Cape, Ph.D. 
Dr. Karl J. Brunings 
W. Vern Hartwell, Ph.D. 
Dr. D. J. Kilian 
Mr. C. C. McDonald 
Dr. John F. Brown, Jr. 
Manager, Life Sciences 
Branch, GE Corporate 
Research & Development 
Dr. Louis G. Nickell 
[ 426 ] 
